| dc.contributor.author | Tamirat mulugeta tolera | |
| dc.contributor.author | Mengist awoke | |
| dc.contributor.author | Abdissa Biruksew | |
| dc.contributor.author | Bokretsion Gidey | |
| dc.contributor.author | Jemal Hussien | |
| dc.date.accessioned | 2026-08-03T06:34:36Z | |
| dc.date.available | 2026-08-03T06:34:36Z | |
| dc.date.issued | 2026-06 | |
| dc.identifier.uri | https://repository.ju.edu.et//handle/123456789/10337 | |
| dc.description.abstract | Malaria remains a major public health problem in Ethiopia, with Plasmodium vivax (P. vivax) accounting for a substantial proportion of cases. Chloroquine combined with primaquine is the first-line treatment for uncomplicated P. vivax infection. Periodic therapeutic efficacy monitoring is essential to ensure the continued effectiveness of this regimen and to inform malaria treatment policy | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Chloroquine | en_US |
| dc.subject | Primaquine | en_US |
| dc.subject | Drug efficacy | en_US |
| dc.subject | Drug resistance | en_US |
| dc.subject | Drug resistance | en_US |
| dc.subject | lasmodium vivax | en_US |
| dc.title | Therapeutic efficacy and safety of chloroquine plus Primaquine for the treatment of uncomplicated Plasmodium vivax infection in metehara sugar factory Hospital: a single arm prospective study | en_US |
| dc.type | Thesis | en_US |